ABCL-274: Outcomes in Patients with Lymphoproliferative Diseases and COVID-19: Results of a Subgroup Analysis of the CHRONOS19 Registry

BACKGROUND: Patients (pts) with lymphoproliferative diseases (LPD) are at high risk of COVID-19 severe and lethal course. OBJECTIVE: To evaluate treatment outcomes and risk factors in pts with LPD and COVID-19 in a real-world setting. METHODS: CHRONOS19 is an ongoing nationwide observational cohort...

Descripción completa

Detalles Bibliográficos
Autores principales: Gavrilina, Olga, Zakurdaeva, Kristina, Vasileva, Anastasia, Vorobyev, Vladimir, Butaev, Lev, Dubov, Vitaly, Dubov, Sergey, Toropova, Inessa, Gavrilova, Lubov, Popova, Marina, Siniaev, Aleksandr, Kaplanov, Kamil, Petrenko, Andrei, Ochirova, Oksana, Sveshnikova, Yulia, Shuvaev, Vasily, Grishunina, Maria, Kunst, Mikhail, Chabaeva, Yulia, Al-Radi, Lyubov, Baryshnikova, Daria, Gilyazitdinova, Elena, Julhakyan, Hunan, Savchenko, Valery
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Elsevier Inc. 2021
Materias:
Aggressive B-Cell Lymphoma
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8404062/
http://dx.doi.org/10.1016/S2152-2650(21)01880-2

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8404062/
http://dx.doi.org/10.1016/S2152-2650(21)01880-2

Ejemplares similares